STAT's The Readout LOUD podcast goes international with a Shanghai dispatch on China's biotech surge
The Readout LOUD podcast, part of STAT's weekly biotech series, is expanding its reach beyond the United States this week. Host Jason Mast reports from Shanghai, where he examines how China's growing drug development capabilities are influencing the global biotech landscape.
The episode includes commentary on the FDA's so-called Overton era, highlighting recent regulatory shifts and their impact on companies worldwide. The discussion also touches on the broader implications for investors and drug developers as Chinese firms accelerate their pipelines.
The piece is authored by Elaine Chen, Adam Feuerstein and Allison DeAngelis, who each bring expertise in biotech trends, regulatory changes and financing of emerging startups.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “The FDA’s Overton era, and dispatches from Shanghai”
read at STAT ↗
comments(0)
5-min edit window · permanent after that